Latest Company Story
Accelerating low-cost point-of-care diagnostics
Acrongenomics | Added: 2 Aug 2006
Acrongenomics and Molecular Vision present an R+D update of their joint collaboration, following th…
Design and manufacturing expansion at Aubrey
Aubrey | Added: 2 Aug 2006
Aubrey, a southern California engineering firm and contract manufacturer specialising in complex el…
Teranode to participate on semantic web panel
Teranode | Added: 2 Aug 2006
Semantic web innovator Dr Eric K Neumann and other industry experts to discuss potentials of semant…
Creating an employee hullabaloo
Genologics | Added: 1 Aug 2006
GenoLogics Life Sciences Software (GenoLogics), a developer of software for life science research, …
Barrie Ward to strengthen CRT's board of directors
Cancer Research UK | Added: 1 Aug 2006
Cancer Research Technology (CRT) has announced the appointment of Dr J Barrie Ward as a non-executi…
Enzyme supply agreement with New England Biolabs
Solexa | Added: 1 Aug 2006
Solexa is commercialising a next-generation sequencing technology which has the potential to produc…
Funding from the Foundation Fighting Blindness
Oxford BioMedica | Added: 1 Aug 2006
Oxford BioMedica announced that the US non-profit organisation, the Foundation Fighting Blindness (…
MoNuDin in the treatment of motor neuron disease
Oxford BioMedica | Added: 1 Aug 2006
Oxford BioMedica presented 'promising' preclinical data from its motor neuron disease programme at …
Metxia enters clinical trials in pancreatic cancer
Oxford BioMedica | Added: 1 Aug 2006
Oxford BioMedica received approval from the UK's Gene Therapy Advisory Committee (GTAC) for MetXia …
NI reports record quarterly revenue
National Instruments | Added: 31 Jul 2006
National Instruments has reported record revenue in Q2 2006 of $160 million, a 14 percent USD incre…
Millipore in win-win situation
Merck | Added: 31 Jul 2006
Millipore was awarded top honors for the most attractive, informative and "impossible to miss" boot…
Oxford Biomedica acquires Chiron patents
Oxford BioMedica | Added: 31 Jul 2006
Oxford BioMedica has signed an agreement with Chiron to acquire certain patent families from Chiron…
Scientists pioneer motor neuron disease treatment
Oxford BioMedica | Added: 31 Jul 2006
Amyotrophic Lateral Sclerosis (ALS), the most prevalent form of motor neuron disease, causes adult-…
FDA approval for trial of Trovax in renal cancer
Oxford BioMedica | Added: 31 Jul 2006
The US Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) applicatio…
Grant from UK gene therapy research programme
Oxford BioMedica | Added: 31 Jul 2006
The UK Department of Health has awarded Oxford BioMedica £0.5 million to develop its proprietary Le…
LentiVector licensing agreement with Merck
Oxford BioMedica | Added: 31 Jul 2006
Oxford BioMedica has signed a licence agreement for its LentiVector technology with Merck
Phase II trial with TroVax in colorectal cancer
Oxford BioMedica | Added: 31 Jul 2006
Oxford BioMedica announces that Cancer Research UK has received approval to start a Phase II trial …
Further contract award at Cambridge research park
ISG Jackson | Added: 28 Jul 2006
Jackson Construction has won a further £3.4 million project at Chesterford Research Park, near Camb…
New Scottish labs to analyse tomorrow's medicines
Tepnel Life Sciences | Added: 28 Jul 2006
Project will provide a valuable resource to the fast growing biological medicines sector through ph…
Cytochrome P450 enzymes in cancer gene therapy
Oxford BioMedica | Added: 28 Jul 2006
Oxford BioMedica has signed an agreement with Massachusetts General Hospital, Boston University and…
